Return
Company Page
Reprogram Biosciences
Founders
Reprogram Biosciences is a preclinical oncology biotechnology company developing a first-in-class platform that uses mRNA-encoded gene combinations delivered directly into tumors to reprogram cancer cells into immune-activating antigen-presenting cells. Its proprietary CellRecodeX AI discovery engine integrates biological foundation models to accelerate therapeutic candidate identification and pipeline expansion across solid tumor indications.
Company Founded in 2025
Healthtech & Biotech